About Us

Allergic diseases have become an increasingly important chronic disease and public health issue in Australia and other developed countries over the last two decades, contributing to increased demand for medical services, significant economic cost of care and reduced quality of life of people with allergic diseases and their carers. Currently affecting more than 4 million Australians, the rapid and continuing rise of allergic diseases is therefore a serious public health issue that requires action by all levels of government and the community. 

To address these issues, the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA), as the leading medical and patient organisations for allergy in Australia, have developed the first National Allergy Strategy for Australia,  in collaboration with other stakeholder organisations.  An important guiding principle is to be patient and consumer focused, and this is reflected in the Mission of the National Allergy Strategy:

To improve the health and quality of life of Australians with allergic diseases, and minimise the burden of allergic diseases on individuals, their carers, healthcare services and the community.

The goals of the National Allergy Strategy are as follows:

  1. Standards of Care
    Develop standards of care to improve the health and quality of life of people with allergic diseases.
  2. Access to Care
    Ensure timely access to appropriate healthcare management for people with allergic diseases.
  3. Information, Education and Training
    Improve access to best-practice, evidence-based and consistent information, education and training on allergic diseases for health professionals, people with allergic diseases, consumers, carers and the community.
  4. Research
    Promote patient-focused research to prevent the development of allergic diseases and improve the health and quality of life of people with allergic diseases.
  5. Prioritised Chronic Disease
    Recognition of allergic diseases as a prioritised chronic disease and National Health Priority Area.

It is important to note that the content of the National Allergy Strategy has not been influenced by financial supporters.

Content updated 26 August 2016